Document mpM76GyXJ8Gdjdo4X0YyrQnLk
2^
C%e*nbcU!h
CHEMICALS GROUP
Five Executive Mall, Swadtsford Road, Wayna, Pa, 19087
12 November 1974
Dr. Marvin Kuschner Professor Chairman Department of Pathology State University of New York S. Campus Health Science Center Building 6, Room 133 Stoneybrook, New York 11790
Dear Dr. Kuschner:
I have attached for your review, prior to our meeting in Trexlertown Monday afternoon, a proposed agenda that was worked out by Mr. Leonard Ball, our Corporate Safety Director, following Martin Spurlock's visit week before last.
I am also attaching a letter from H. W. Smith in Len's Department, outlining a diagram of one possible flow of examination routine.
We would like to finalize the agenda with you Monday, prior to the Tuesday meeting with the doctors.
I understand, from Martin Spurlock, that there is in existence, a
record form agreed upon by Drs. Blalock and Beidleman but that it is not in use. Perhaps we should have this as a starter on the agenda also.
We have scheduled our MID (computer) people to be with us Wednesday. By then we hope to have resolved what examination will be made, what records we will keep, and the modes of recall desired.
I look forward to meeting you Monday afternoon around 1:00 P.M. in Mr. Len Ball' s office at our Trexlertown headquarters and working with you again.
Sincerely,
HLW:heg Attachments
?ard L. Watson Administrative Manager - Manufacturing
bcc: *
A. R. Adams
W. L. Ball
J. T. Barr i . L. Carey ----------R. Fleming J. T. Sebastianelli H. W. Smith E. M. Spurlock
received
KOV 13 $74
J. T. BARR
AP00002644
From
INTEROFFICE MEMORANDUM
H L. y/,fifgt>;MNovemI?er 4> 19?4 '^Subject PVC Physical Examinations
H. L V/ATSON
M. Spurlock/H, Watson`S H. W. Smith
Valley Forge
(Location, Organization, or Department)
Safety - Trexlertown
(Location, Organization, or Department)
Attached is a flow diagram of the PVC physical examinations with, the laboratory work included. This model is taken from Dr, Hyman's work and is intended as a guide only. Dr. Kuschner will have to give his approval and modifications as necessary. Your approval of this model is required for insertion into the program on November 19th and 20th. May I please have your immediate comments.
dhd
(320)
AP00002645
AP00002646
c)
PROPOSED AGENDA FOR MEETING WITH CONSULTING PHYSICIANS
A. Purpose of Meeting To review as may be necessary the medical requirements for employees who may be exposed to vinyl chloride monomer; to establish a protocal for a continuing health surveillance program for these employees. The protocal must consider the employee from time of employment throughout his working career with the company. The protocal must also be compatable with the company's intent to computerize each employee's medical hIstory.
B. I. Medical record form - It is suggested that the forms now being used at Pace and Calvert City be used as a point of departure. Specific minimum examination requirements should be established for a. pre employment or pre assignment b. six (6) months (employees with 10 years or more exposure) c. annual (employees with less than 10 years exposure) d. employees exposed to an emergency
2. Are any special requirements needed because of sex or race? .
3. What values are to be considered normal?
4. Are there any special neurological requirements or problems?
C. Coordination between the Consultant and the Contract Physicians.
D. Handling of medical information obtained as a result of the medical sur veillance program that may not be pertinent to purpose of the program but may be of concern to the employee. 1. Release of information to the employee 2. Release of report to the employee's private physician
AP00002647
Proposed Agenda for Meeting with Consulting Physicians ... Page 2 E. Confidentiality of records - It is requested that our Medical Con
sultant recommend the proper handling, storage and use of the medical information gathered by this program to insure the appropriate degree of privacy for the employee while obtaining the necessary information tor employee's health and safety, and federal regulations.
AP00002648
